The Medica share price – where next?

The Medica share price – where next?

Article image

The Medica (LON:MGP) share price has risen by 3.96% over the past month and it’s currently trading at 160. For investors considering whether to buy, hold or sell the stock, the question now is whether this price run will continue.

According to the company’s analysts, there are certainly reasons to think it will continue to perform well in the year ahead. In terms of trading recommendations, Medica currently has:

  • 3 Buy recommendations
  • 0 Hold recommendations
  • 1 Sell recommendations

This suggests that analysts are generally positive about the outlook.

Going beyond analyst recommendations

At its current price of 160, shares in Medica are trading at a discount of -3.37% to its 52 week high price. The 1-year performance of the shares has been 21.2%.


While analyst forecasts can be a useful guide to what City 'experts' think about a stock's near term future, they can be unreliable. To get a better idea about the strengths and weaknesses of Medica it's worth doing some investigation yourself. Indeed, we've identified some areas of concern with Medica that you can find out about here.


About us

Stockopedia helps individual investors make confident, profitable choices in the stock market. Our StockRank and factor investing toolbox unlocks institutional-quality insights into thousands of global stocks. Voted “Best Investment Research Tools” and “Best Research Service” at the 2021 UK Investor Magazine awards.

As per our Terms of Use, Stockopedia is a financial news & data site, discussion forum and content aggregator. Our site should be used for educational & informational purposes only. We do not provide investment advice, recommendations or views as to whether an investment or strategy is suited to the investment needs of a specific individual. You should make your own decisions and seek independent professional advice before doing so. Remember: Shares can go down as well as up. Past performance is not a guide to future performance & investors may not get back the amount invested.